Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMC Cancer|August 14, 2016
IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosisPhilippos Perimenis, Apostolos Galaris, Alexandra Voulgari, et al.
Journal of Autoimmunity|September 1, 2019
Autotaxin and chronic inflammatory diseasesChristiana Magkrioti, Apostolos Galaris, Paraskevi Kanellopoulou, et al.
Gels (Basel, Switzerland)|September 26, 2025
Amphiphilic Thermoresponsive Triblock PLA-PEG-PLA and Diblock mPEG-PLA Copolymers for Controlled Deferoxamine DeliveryNikolaos D Bikiaris, Ermioni Malini, Evi Christodoulou, et al.
Biomedicines|February 25, 2022
Obesity Reshapes the Microbial Population Structure along the Gut-Liver-Lung Axis in MiceApostolos Galaris, Dionysios Fanidis, Elli-Anna Stylianaki, et al.
Frontiers in Medicine|September 25, 2023
Increased lipocalin-2 expression in pulmonary inflammation and fibrosisApostolos Galaris, Dionysios Fanidis, Eliza Tsitoura, et al.
Frontiers in Immunology|December 6, 2021
Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased MortalityEliza Tsitoura, Athina Trachalaki, Eirini Vasarmidi, et al.
Nature Communications|September 21, 2023
SRC and TKS5 mediated podosome formation in fibroblasts promotes extracellular matrix invasion and pulmonary fibrosisIlianna Barbayianni, Paraskevi Kanellopoulou, Dionysios Fanidis, et al.
Diagnostics (Basel, Switzerland)|March 29, 2023
SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung FibroblastsTheodoros Karampitsakos, Apostolos Galaris, Ilianna Barbayianni, et al.
Nature Communications|January 21, 2026
Versican expression from lung fibroblasts suppresses pulmonary fibrosisParaskevi Kanellopoulou, Ilianna Barbayianni, Dionysios Fanidis, et al.
Respiratory Research|November 14, 2023
Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosisTheodoros Karampitsakos, Apostolos Galaris, Serafeim Chrysikos, et al.
Pageof 1